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This article provides an overview of the 
current  methods  of  diagnosis  and  treat-
ment of patients with vertigo, dizziness, or 
imbalance, as well as an analysis of ongo-
ing problems besetting the field of neu-
ro-otology. Aims and challenges are also 
described with the hope of stimulating basic 
and clinical research on these very frequent 
symptoms.
Vertigo  and  dizziness  are  among  the 
most  frequent  symptoms  that  patients 
  experience at some time in their lives. With 
a lifetime prevalence of about 30% and an 
annual incidence that increases with age, 
vertigo  and  dizziness  will  become  even 
more important in the future. Despite this 
high prevalence and burden of disease, con-
siderable challenges remain.
•	 Most	 patients	 with	 acute	 vertigo	 and	
dizziness are uncertain who to consult, 
because  their  problem  lies  inbetween 
the  specializations  of  ear,  nose,  and 
throat  (ENT)  and  neurology,  and  in 
some  cases,  ophthalmology,  internal 
medicine, or psychiatry.
•	 While	neurologists	are	very	familiar	with	
the anatomy, physiology, and pathophy-
siology  of  the  central  nervous  system 
(central  vestibular  and  ocular  motor 
systems),  ENT  physicians  specialize  in 
the  peripheral  vestibular  and  audiolo-
gical  systems.  However,  very  few  have 
detailed knowledge of both the central 
and	peripheral	systems.	Moreover,	most	
ENT physicians practice mainly as ENT 
surgeons,  and  therefore,  they  are  not 
necessarily  specialists  on  vertigo  and 
dizziness.
•	 With	 a	 few	 exceptions	 (South	 Korea,	
and	some	centers	in	the	USA,	UK,	and	
Australia) cooperation between neuro-
logy and ENT as well as neuro-otology 
and oto-neurology is far from perfect. 
The underlying diseases resulting in ver-
tigo and dizziness cover a broad spec-
trum of anatomical structures. Possible 
etiologies  include  ischemia,  infection, 
autoimmune  disorders,  mechanical 
inner  ear  disorders,  psychosomatic, 
and somatoform disorders. Therefore, 
the  approach  to  patients  requires  a 
broad-based  knowledge  of  anatomy, 
physiology, pathophysiology, and phar-
macology as well as in-depth practical 
experience with the different methods 
available  for  evaluating  the  vestibular 
and ocular motor systems.
•	 Medical	 education	 in	 neuro-otology	
is also less than optimal. The problem 
begins	 in	 Medical	 School,	 where	 the	
vestibular and ocular motor systems are 
assumed to be among the most complica-
ted anatomical and physiological systems 
of humans. Therefore, most medical stu-
dents are not attracted to this field, which 
may also explain their limited knowledge 
of  the  subject.  This  downward  trend 
continues during post-graduate training 
for  most  neurologists  and  ENT  physi-
cians, and is further exacerbated by the 
above-mentioned overlapping of the two 
disciplines.	Moreover,	to	establish	a	cor-
rect diagnosis, physicians must examine 
the  vestibular,  audiological,  and  ocu-
lar motor systems. Furthermore, many 
physicians  have  difficulties  examining 
the  ocular  motor  system  and  ultima-
tely interpreting their findings. What is 
pathological  and  what  do  the  findings 
mean?  Thus,  topographical  anatomical 
diagnosis remains a challenge: it is impe-
rative to be able to discriminate between 
peripheral and central vestibular lesions 
is imperative.
•	 The	link	between	basic	physiology	and	
the modeling of the vestibular and the 
ocular motor systems, on the one hand, 
and  their  clinical  implications  and 
applications, on the other, are far from 
ideal. While we know the detailed wor-
kings of the vestibular and ocular motor 
systems and can model their function 
and  dysfunction,  this  knowledge  has 
not yet been fully integrated in clinical 
practice.  Conversely,  clinical  findings 
have to be linked with basic knowledge 
in order to stimulate the knowledge of 
physiology and the modeling of these 
systems.
•	 State-of-the-art	randomized	controlled	
clinical trials on the frequent causes of 
vertigo  and  dizziness  as  well  as  their 
underlying  disorders  are  still  lacking. 
This is true for phobic postural vertigo, 
vestibular	migraine,	Menière’s	disease,	
vestibular  paroxysmia,  downbeat  and 
upbeat nystagmus, episodic ataxia, and 
perilymphatic fistula.
•	 The	 number	 of	 studies	 available	 on	
the impact of vertigo and dizziness, as 
well as impaired vestibular function on 
patients’	quality	of	life	and	functioning	
are limited.
•	 Long-term	 studies	 on	 the	 natural	
course of the different forms of vertigo, 
their recurrence rates, or the long-term 
efficacy of available treatments are non-
existent. This is true for most forms of 
vertigo and dizziness.
In brief our growing knowledge of the 
anatomy and physiology of the vestibular 
and related ocular motor systems, as well 
as  basic  and  clinical  research  must  still 
overcome a number of shortcomings and 
limitations to improve diagnosis, develop 
new diagnostic criteria, and better under-
stand the pathophysiology of these disor-
ders. Hopefully, new treatment strategies 
and  state-of-the-art  prospective  clinical 
trials will improve the quality of life and 
functioning in patients with vertigo and 
dizziness.
How can we solve tHese 
worldwide problems?
First, we must increase worldwide awareness 
of the impact of vertigo and dizziness. While 
acute vertigo and dizziness may be the first 
sign of severe neurological disorders such 
as brainstem or cerebellar ischemia, chronic 
vertigo, dizziness, and balance disorders – in 
particular, if patients are not aware of their 
cause and are not adequately treated – have 
a considerable socio-economic impact.
Second,	it	is	very	important	to	improve	
the cooperation between ENT, neurology, 
neuro-ophthalmology,  ophthalmology, 
and psychiatry, because many patients fall Strupp  Perspectives in vertigo and dizziness
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vestibulopathy,	Menière’s	disease,	downbeat	
nystagmus, and episodic ataxia, to further 
enhance our knowledge about the histologi-
cal changes and to differentiate possibly dif-
ferent forms. Finally, vestibular prostheses are 
being developed for patients with a complete 
bilat  eral vestibular failure but they still have 
to be implemented in clinical use.
The long-term goals of these measures 
should be
1.  to improve our knowledge of the patho-
logical  anatomy  and  pathophysiology 
of the different causes of vertigo and 
dizziness  arising  from  the  labyrinth, 
vestibular nerve, brainstem, and cere-
bellum. Based on this knowledge, new 
therapeutic  paradigms  can  be  deve-
loped, particularly to improve central 
vestibular compensation after periphe-
ral and central vestibular lesions.
2.  to define worldwide accepted diagno-
stic criteria for the different causes of 
vertigo  and  dizziness,  which  can  also 
form the basis for future clinical trials.
3.  to  improve  the  quality  of  life  and 
functioning  of  these  patients  with 
physiotherapy,  pharmacotherapy,  psy-
chotherapy,  or  surgery  after  correct 
diagnoses have been made and specific 
therapies established.
Looking	back	at	the	developments	in	the	
field over the last 20 years, we are highly 
optimistic that most of these goals will be 
reached within the next 20 years.
Submission	of	manuscripts	dealing	with	
the above-mentioned aspects will be very 
welcomed at Frontiers in Neuro-otology.
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•	 Menière’s	disease	–	there	is	still	a	ple-
thora of recommended treatments for 
this disorder, including a salt-free diet, 
diuretics,  aminoglycosides,  corticoste-
roids, betahistine, change of pressure in 
the middle ear, and surgery.
•	 Vestibular	neuritis	–	the	potential	effi-
cacy of corticosteroids and physiothe-
rapy must still be determined.
•	 Vestibular	migraine	–	the	acute	effects	
of  drugs  (also  used  in  the  treatment 
of migraine with or without aura), as 
well as the prophylactic treatment with 
beta-blockers,  topiramate,  or  valproic 
acid must be investigated.
•	 Perilymphatic	 fistula	 –	 the	 natural	
course of this disorder should be com-
pared with canal plugging, canal resur-
facing, as well as fixation of the stapes.
•	 Bilateral	 vestibulopathy	 –	 the	 efficacy	
of physiotherapy and possible efficacy 
of  certain  drugs  to  improve  the  gain 
of the vestibulo-ocular reflex must be 
evaluated.
•	 Vestibular	paroxysmia	–	treatment	with	
agents such as carbamazepine or oxcar-
bamazepine must be investigated.
•	 Episodic	 ataxia	 –	 the	 efficacy	 of	 ace-
tazolamide  (never  established  in  a 
placebo-controlled trial) as well as the 
aminopyridines must be clarified.
•	 Phobic	postural	vertigo	–	the	potential	
efficacy of cognitive behavioral therapy 
and  pharmacotherapy,  for  example 
with selective serotonin-reuptake inhi-
bitors, must be established.
•	 The	mechanisms	of	upbeat	and	down-
beat  nystagmus,  acquired  pendular 
nystagmus, and other forms of nystag-
mus must be clarified.
•	 The	 anterior	 canal	 variant	 of	 benign	
paroxysmal  positioning  vertigo  must 
also be elucidated, in order to evaluate 
diagnostic criteria, prevalence, and tre-
atment. There is an ongoing debate on 
whether this variant exists at all.
Further, histopathological post-mortem 
studies will require the establishment of brain 
banks  on  frequent  disorders  like  bilateral 
between	 these	 different	 specialties.	 Such	
cooperation  requires  the  establishment 
of  specialized  interdisciplinary  centers, 
in  which  ENT  specialists,  neurologists, 
ophthalmologists, psychiatrists, psycholo-
gists, cardiologists, radiologists, and neu-
roradiologists  closely  collaborate  and 
examine patients together as a team. An 
example of such a center is the newly estab-
lished Integrated Center for Research and 
Treatment of Vertigo, Dizziness and Ocular 
Motor Disorders (IFBLMU) at the University 
of	 Munich.	 The	 German	 Ministry	 of	
Research  and  Education  will  fund  this 
center with 5 million Euros per year for 
5–10  years.  This  novel  patient-centered 
approach will allow the establishment of 
new paradigms to overcome the boundaries 
between these disciplines and thus have an 
enduring effect.
Third,  only  such  an  interdisciplinary 
approach will increase the knowledge and 
improve the skills of medical students and 
even physicians experienced in this field. 
Interdisciplinary thinking will be impera-
tive in addition to a specialized curricu-
lum covering vertigo, dizziness, imbalance, 
ocular motor, and gait disorders. It would 
suffice to have just one or two such centers 
per country. This approach would also have 
a snowballing effect leading to the creation 
of special examinations and certificate of 
qualifications.
Fourth, diagnostic criteria for some of 
the vestibular and ocular motor disorders 
have to be better defined and then inter-
nationally	recognized.	The	Bárány	Society	
therefore recently proposed an initiative, 
led by Dr. Alexandre Bisdorff, to establish 
committees that would formulate such cri-
teria for the different forms of vertigo and 
dizziness. This has implications for clini-
cal practice as well as for further clinical 
trials.
Fifth, multicenter, multinational pro-
spective  randomized  placebo-  controlled 
trials are urgently needed for a number of 
these	disorders.	Such	studies	should	also	
measure the quality of life and functioning 
whenever possible. Examples are: